English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease Journal article
Rostam M.A., Piva T.J., Rezaei H.B., Kamato D., Little P.J., Zheng W., Osman N.. Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease[J]. Clinical and Experimental Pharmacology and Physiology, 2015, 42(2), 117-124.
Authors:  Rostam M.A.;  Piva T.J.;  Rezaei H.B.;  Kamato D.;  Little P.J.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:24 | Submit date：2018/12/21
Atherosclerosis  Cardiovascular Disease  Peptidyl-prolyl Isomerase  Pin1  
Serum nitric oxide synthase activity is a novel predictor of impaired vasorelaxation in rats Journal article
Enoch Chan, Janet Yuen-Yan Chan, Jian-Hong Wu, Chun-Wai Wan, George Pak-Heng Leung, Simon Ming-Yuen Lee, Yiu-Wa Kwan, Shun-Wan Chan. Serum nitric oxide synthase activity is a novel predictor of impaired vasorelaxation in rats[J]. Clinical and Experimental Pharmacology and Physiology, 2012, 39(10), 894-896.
Authors:  Enoch Chan;  Janet Yuen-Yan Chan;  Jian-Hong Wu;  Chun-Wai Wan;  George Pak-Heng Leung; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5 | Submit date：2018/11/06
Cholesterol  Diagnostic  Nitric Oxide Synthase  Serum  Vasorelaxation